Molina Healthcare, Inc. (BIT:1MOH)
Italy
· Delayed Price · Currency is EUR 275.90
-8.20 (-2.89%)
At close: May 2, 2025
Molina Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Premiums & Annuity Revenue | 39,751 | 38,627 | 32,529 | 30,883 | 26,855 | 18,299 | Upgrade
|
| Total Interest & Dividend Income | 451 | 453 | 404 | 149 | 42 | 59 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1 | -1 | -10 | -6 | 10 | - | Upgrade
|
| Other Revenue | 86 | 85 | 80 | 75 | 77 | 17 | Upgrade
|
| Total Revenue | 40,289 | 39,164 | 33,003 | 31,101 | 26,984 | 18,375 | Upgrade
|
| Revenue Growth (YoY) | 16.24% | 18.67% | 6.12% | 15.26% | 46.85% | 12.45% | Upgrade
|
| Policy Benefits | 35,493 | 34,428 | 28,669 | 27,175 | 23,704 | 15,820 | Upgrade
|
| Depreciation & Amortization | 189 | 186 | 171 | 176 | 131 | 88 | Upgrade
|
| Selling, General & Administrative | 2,687 | 2,626 | 2,347 | 2,208 | 1,996 | 1,423 | Upgrade
|
| Other Operating Expenses | 87 | 100 | 87 | 58 | 61 | 37 | Upgrade
|
| Total Operating Expenses | 38,572 | 37,456 | 31,389 | 29,720 | 25,964 | 17,425 | Upgrade
|
| Operating Income | 1,717 | 1,708 | 1,614 | 1,381 | 1,020 | 950 | Upgrade
|
| Interest Expense | -134 | -118 | -109 | -110 | -120 | -102 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | -25 | - | Upgrade
|
| EBT Excluding Unusual Items | 1,583 | 1,590 | 1,505 | 1,271 | 875 | 848 | Upgrade
|
| Merger & Restructuring Charges | -3 | -1 | - | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | -208 | - | - | Upgrade
|
| Legal Settlements | - | - | - | - | - | 128 | Upgrade
|
| Other Unusual Items | - | - | -41 | - | - | -15 | Upgrade
|
| Pretax Income | 1,580 | 1,589 | 1,464 | 1,063 | 875 | 961 | Upgrade
|
| Income Tax Expense | 404 | 410 | 373 | 271 | 216 | 288 | Upgrade
|
| Net Income | 1,176 | 1,179 | 1,091 | 792 | 659 | 673 | Upgrade
|
| Net Income to Common | 1,176 | 1,179 | 1,091 | 792 | 659 | 673 | Upgrade
|
| Net Income Growth | 9.80% | 8.07% | 37.75% | 20.18% | -2.08% | -8.68% | Upgrade
|
| Shares Outstanding (Basic) | 57 | 57 | 58 | 58 | 58 | 59 | Upgrade
|
| Shares Outstanding (Diluted) | 57 | 58 | 58 | 59 | 59 | 60 | Upgrade
|
| Shares Change (YoY) | -2.32% | -0.69% | -0.68% | -0.17% | -2.17% | -6.70% | Upgrade
|
| EPS (Basic) | 20.79 | 20.54 | 18.91 | 13.70 | 11.40 | 11.41 | Upgrade
|
| EPS (Diluted) | 20.69 | 20.42 | 18.77 | 13.55 | 11.25 | 11.23 | Upgrade
|
| EPS Growth | 12.28% | 8.79% | 38.52% | 20.44% | 0.18% | -2.09% | Upgrade
|
| Free Cash Flow | 525 | 544 | 1,578 | 682 | 2,042 | 1,824 | Upgrade
|
| Free Cash Flow Per Share | 9.24 | 9.43 | 27.16 | 11.66 | 34.85 | 30.45 | Upgrade
|
| Operating Margin | 4.26% | 4.36% | 4.89% | 4.44% | 3.78% | 5.17% | Upgrade
|
| Profit Margin | 2.92% | 3.01% | 3.31% | 2.55% | 2.44% | 3.66% | Upgrade
|
| Free Cash Flow Margin | 1.30% | 1.39% | 4.78% | 2.19% | 7.57% | 9.93% | Upgrade
|
| EBITDA | 1,837 | 1,825 | 1,727 | 1,503 | 1,110 | 1,000 | Upgrade
|
| EBITDA Margin | 4.56% | 4.66% | 5.23% | 4.83% | 4.11% | 5.44% | Upgrade
|
| D&A For EBITDA | 120 | 117 | 113 | 122 | 90 | 50 | Upgrade
|
| EBIT | 1,717 | 1,708 | 1,614 | 1,381 | 1,020 | 950 | Upgrade
|
| EBIT Margin | 4.26% | 4.36% | 4.89% | 4.44% | 3.78% | 5.17% | Upgrade
|
| Effective Tax Rate | 25.57% | 25.80% | 25.48% | 25.49% | 24.69% | 29.97% | Upgrade
|
| Revenue as Reported | 41,866 | 40,650 | 34,072 | 31,974 | 27,771 | 19,423 | Upgrade
|
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.